You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 13, 2025

Tajikistan Drug Patents


✉ Email this page to a colleague

« Back to Dashboard


Drug Patents in Tajikistan and US Equivalents

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
Patent NumberEstimated ExpirationEquivalent US PatentUS Expiry DateGeneric NameUS ApplicantUS Tradename
275 ⤷  Try for Free 5134127 2010-01-23 amiodarone hydrochloride Baxter Hlthcare NEXTERONE
275 ⤷  Try for Free 5376645 2010-01-23 amiodarone hydrochloride Baxter Hlthcare NEXTERONE
392 ⤷  Try for Free 5981589 2014-05-24 glatiramer acetate Teva Pharms Usa COPAXONE
392 ⤷  Try for Free 6054430 2014-05-24 glatiramer acetate Teva Pharms Usa COPAXONE
392 ⤷  Try for Free 6342476 2014-05-24 glatiramer acetate Teva Pharms Usa COPAXONE
392 ⤷  Try for Free 6362161 2014-05-24 glatiramer acetate Teva Pharms Usa COPAXONE
392 ⤷  Try for Free 6620847 2014-05-24 glatiramer acetate Teva Pharms Usa COPAXONE
>Patent Number>Estimated Expiration>Equivalent US Patent>US Expiry Date>Generic Name>US Applicant>US Tradename
Showing 1 to 7 of 7 entries

Patentability, Enforceability, and Scope of Claims for Biopharmaceutical Patents in Tajikistan

Overview of Patent Protection in Tajikistan

Tajikistan offers a framework for protecting intellectual property, including patents, through various international conventions and national laws. Here are the key insights for biopharmaceutical patents.

International Conventions and National Laws

Tajikistan is a signatory to several international conventions, including 18 of the 26 WIPO treaties, which provide a foundation for intellectual property protection. This includes the Patent Law Treaty and the Trademark Law Treaty, ensuring a level of harmonization with global standards[2].

Patent Registration Procedure

Filing and Examination

To register a patent in Tajikistan, applicants must follow a specific procedure. The application undergoes a formal examination lasting 2-3 months, followed by a substantive examination if requested by the applicant within three years from the filing date. The substantive examination is crucial for determining the patentability of the invention[1].

Required Documents

For filing, applicants need to provide detailed documentation, including the specification with claims, abstract, and drawings. A Power of Attorney simply signed and stamped by the applicant is also required, which should be submitted within two months from the application filing date[1].

Priority and National Phase

Tajikistan allows for the national phase entry of PCT applications within 30 months (Chapter I) or 31 months (Chapter II) from the priority date. Conventional patent applications must be filed within 12 months from the priority date[1].

Validity and Extension of Patents

General Validity

Patents in Tajikistan are valid for 20 years from the filing date. This period can be extended for pharmaceutical patents and patents for agrochemicals by an additional 5 years through a Supplementary Protection Certificate (SPC)[1].

Novelty and Grace Period

Novelty Requirement

The invention must be novel to be patentable. There is a 6-month novelty grace period from the disclosure of the information on the invention before filing an application[1].

Enforceability of Patents

Current Challenges

Despite the legislative framework, enforcement of intellectual property rights in Tajikistan remains weak. IPR infringement is widespread, and the government faces challenges in developing and strengthening enforcement mechanisms. The Unit to Combat IP Crimes within the Ministry of Internal Affairs is responsible for addressing these issues, but the number of detected IPR violations remains low[2].

Customs and Border Protection

Tajikistan has amended its Customs Code to provide ex officio authority to customs officers to seize and destroy counterfeit goods. However, the effectiveness of these measures is limited by the lack of resources and technical assistance[2].

Scope of Claims for Biopharmaceutical Patents

General Principles

The scope of patent claims in Tajikistan is determined by the patentability requirements, which include novelty, inventiveness, and industrial applicability. The claims must be clear, concise, and supported by the specification to enable any person skilled in the art to make and use the invention[1].

Challenges in Biotechnology

Biopharmaceutical patents often involve complex technologies, such as genetic engineering and therapeutic antibodies. These inventions require detailed disclosures, including sequence listings and depositing micro-organisms, which can be challenging given the limited technological capabilities of the patent office[4].

Best Practices for Biopharmaceutical Patent Applications

Detailed Disclosure

Applicants should ensure that their patent applications provide full, clear, and concise descriptions of the invention. This includes all necessary information to enable a person skilled in the art to execute the invention in the best possible manner[4].

Compliance with International Standards

Given Tajikistan's adherence to international conventions, it is advisable to align patent applications with global standards. This includes complying with the requirements for written description and enablement, similar to those in other jurisdictions[2].

Examples and Case Studies

Patent Manipulation

While not specific to Tajikistan, the practice of patent manipulation, as seen in cases like AbbVie's Humira, highlights the importance of transparent and ethical patent filing practices. This involves avoiding excessive patent filings aimed at extending exclusivity beyond the original 20-year term[5].

Key Takeaways

  • Patent Registration: The process in Tajikistan involves formal and substantive examinations, with a validity term of 20 years and possible extensions for pharmaceutical and agrochemical patents.
  • Enforceability: Despite legislative protections, enforcement of IPR remains weak, with a need for stronger mechanisms and technical assistance.
  • Scope of Claims: Biopharmaceutical patents require detailed disclosures and compliance with international standards to ensure patentability.
  • Best Practices: Ensure full and clear descriptions in patent applications, and align with global standards to facilitate smooth processing.

FAQs

Q: How long does the patent registration process take in Tajikistan?

A: The patent registration process in Tajikistan typically takes from 2 to 4 years[1].

Q: Can foreign applicants file patent applications in Tajikistan without local representation?

A: No, foreign applicants must be represented before the Office by a registered Tajik patent attorney[1].

Q: What is the validity term of a patent in Tajikistan?

A: The validity term of a patent in Tajikistan is 20 years from the filing date, with possible extensions for pharmaceutical and agrochemical patents[1].

Q: How does Tajikistan enforce intellectual property rights?

A: Despite legislative protections, enforcement of IPR in Tajikistan remains weak, with limited detections and seizures of counterfeit goods[2].

Q: What are the key documents required for filing a patent application in Tajikistan?

A: Key documents include the specification with claims, abstract, drawings, and a Power of Attorney simply signed and stamped by the applicant[1].

Sources

  1. MSP Corporate: PATENT in Tajikistan | MSP
  2. U.S. Department of Commerce: Tajikistan - Protecting Intellectual Property
  3. DigitalCommons@NYLS: Eviscerating Patent Scope
  4. WIPO: STUDY ON PATENTS AND THE PUBLIC DOMAIN
  5. Pharmaceutical Technology: Exploring companies' manipulation of pharma patents

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.